rutecarpine has been researched along with Cardiovascular Diseases in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Li, WQ; Li, YJ; Ma, WJ; Yin, YC; Zhang, BK | 1 |
| Li, JJ; Tian, KM; Xu, SW | 1 |
| Gu, JA; Huang, SH; Huang, ST; Lee, CM; Lin, CM; Lin, FY; Rau, TG; Yang, CH; Yang, WC | 1 |
2 review(s) available for rutecarpine and Cardiovascular Diseases
| Article | Year |
|---|---|
Calcitonin gene‑related peptide‑mediated pharmacological effects in cardiovascular and gastrointestinal diseases (Review).
Topics: Calcitonin Gene-Related Peptide; Cardiovascular Diseases; Gastrointestinal Diseases; Gene Expression Regulation; Humans; Indole Alkaloids; Molecular Targeted Therapy; Nitroglycerin; Quinazolines; Up-Regulation | 2021 |
Rutaecarpine: A promising cardiovascular protective alkaloid from Evodia rutaecarpa (Wu Zhu Yu).
Topics: Alkaloids; Animals; Anti-Inflammatory Agents; Antioxidants; Cardiotonic Agents; Cardiovascular Diseases; Evodia; Humans; Hypolipidemic Agents; Indole Alkaloids; Platelet Aggregation Inhibitors; Quinazolines; Vasodilator Agents | 2019 |
1 other study(ies) available for rutecarpine and Cardiovascular Diseases
| Article | Year |
|---|---|
Low-cytotoxic synthetic bromorutaecarpine exhibits anti-inflammation and activation of transient receptor potential vanilloid type 1 activities.
Topics: Anti-Inflammatory Agents; Cardiovascular Diseases; Drugs, Chinese Herbal; Evodia; Gene Expression Regulation; Humans; Indole Alkaloids; Inflammation; Macrophages; Nitric Oxide Synthase Type II; Quinazolines; TRPV Cation Channels | 2013 |